Related Experiment Video
Updated: May 23, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets
Aljoša Smajić1, Thomas Steger-Hartmann2, Gerhard F Ecker1
1Department of Pharmaceutical Sciences, University of Vienna, Vienna 1090, Austria.
Abstract:
When applying machine learning (ML) approaches for the prediction of bioactivity, it is common to collect data from different assays or sources and combine them into single data sets. However, depending on the data domains and sources from which these data are retrieved, bioactivity data for the same macromolecular target may show a high variance of values (looking at a single compound) and cover very different parts of the chemical space as well as the bioactivity range (looking at the whole data set). The effectiveness and applicability domain of the resulting prediction models may be strongly influenced by the sources from which their training data were retrieved. Therefore, we investigated the chemical space and active/inactive distribution of proprietary pharmaceutical data from Bayer AG and the publicly available ChEMBL database, and their impact when applied as training data for classification models. For this end, we applied two different sets of descriptors in combination with different ML algorithms. The results show substantial differences in chemical space between the two different data sources, leading to suboptimal prediction performance when models are applied to domains other than their training data. MCC values between -0.34 and 0.37 among all targets were retrieved, indicating suboptimal model performance when models trained on Bayer AG data were tested on ChEMBL data and vice versa. The mean Tanimoto similarity of the nearest neighbors between these two data sources indicated similarities for 31 targets equal to or less than 0.3. Interestingly, all applied methods to assess overlap of chemical space of the two data sources to predict the applicability of models beyond their training data sets did not correlate with observed performances. Finally, we applied different strategies for creating mixed training data sets based on both public and proprietary sources, using assay format (cell-based and cell-free) information and Tanimoto similarities.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Statistical Software for Data Analysis and Clinical Trials